Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection

International Journal of Gynecology and Obstetrics

Volumn 73, Issue 3, 2001, Pages 279-281

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ZIDOVUDINE;

CESAREAN SECTION; FETOMATERNAL TRANSFUSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; NOTE; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS LOAD; ARTICLE; DISEASE TRANSMISSION; EVIDENCE BASED MEDICINE; FEMALE; GESTATIONAL AGE; HIGH RISK PREGNANCY; INFORMED CONSENT; METHODOLOGY; OBSTETRICS; PATIENT EDUCATION; PATIENT PARTICIPATION; PREGNANCY COMPLICATION; RISK FACTOR; STANDARD;

CESAREAN SECTION; DISEASE TRANSMISSION, VERTICAL; EVIDENCE-BASED MEDICINE; FEMALE; GESTATIONAL AGE; HIV INFECTIONS; HUMANS; INFORMED CONSENT; OBSTETRICS; PATIENT EDUCATION; PATIENT PARTICIPATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY, HIGH-RISK; RISK FACTORS; VIRAL LOAD;

EID: 0035375812     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(01)00412-X     Document Type: Note

References (13)

1. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331:1173-1180
2. Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA 3rd, Whitehouse J, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999;341:385-393
3. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn T, Burchett SK, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999;341:394-402
4. Kind C, Rudin C, Siegrist CA, Wyler CA, Biedermann K, Lauper U, et al. Prevention of vertical HIV transmission: Additive protective effect of elective cesarean section and zidovudine prophylaxis. AIDS 1998;12:205-210
5. Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Benifla JL, Delfraissy JF, et al. Perinatal HIV-1 transmission: Interaction between zidovudine prophylaxis and mode of delivery in the French perinatal cohort. JAMA 1998;280:55-60
6. The European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomized clinical trial. Lancet 1999;353:1035-1039
7. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: A meta-analysis of 15 prospective cohort studies. N Engl J Med 1999;340:977-987
8. Nielsen TF, Hakegaard KH. Postoperative cesarean section morbidity: A prospective study. Am J Obstet Gynecol 1983;146:911-915
9. Semprini AE, Castagna C, Ravizza M, Fiore S, Savasi V, Muggiasca ML, et al. The incidence of complications after cesarean section in 156 HIV-positive women. AIDS 1996;9:913-917
10. Bulterys M, Chao A, Dushimimana A, Saah A. Fatal complications after cesarean section in HIV-infected women. AIDS 1996;10:923-924
11. Centers for Disease Control and Prevention. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Morb Mortal Wkly Rep 1998;47(RR-5):1-82
12. Duff P, Robertson AW, Read JA. Single-dose cefazolin versus cefonicid for antibiotic prophylaxis in cesarean delivery. Obstet Gynecol 1987;70:718-721
13. Centers for Disease Control. Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR Morb Mortal Wkly Rep 1988;37:377-382;387-388